Newly Published Roswell Park Research Opens Up New Avenues for Cancer Immunotherapy Targeting Survivin – Benzinga
|
Newly Published Roswell Park Research Opens Up New Avenues for Cancer Immunotherapy Targeting Survivin
Benzinga New research from Roswell Park Comprehensive Cancer Center and MimiVax LLC shows that one of the most commonly occurring molecules in cancer cells may be an attractive target for a broad range of immunotherapy approaches, including CAR T, or chimeric … |
